The cost of a missed diagnosis can be devastating. Troy Warshel’s severe reaction to capecitabine was not a standard side effect—it was from a metabolic abnormality (DPD Deficiency). Routine pre-tr...

Help us advocate for universal DPYD testing before #capecitabine and #5FU for safer cancer care! FDA black box warning added in October 2025, yet patients are not being offered DPYD testing or being...

GivingTuesday is tomorrow! We need your help to get to the finish line: universal DPYD testing before #capecitabine and #5FU chemotherapy. Because of supporters like you, some cancer patients are...

We highlight clinics that are leading the way in patient safety by pre-screening for DPD deficiency prior to 5FU/Xeloda chemotherapy. See: https://lnkd.in/eXSNyeVk It is sad that 2 of the top rated...

An estimated 1300 lives are lost annually in the US because screening has not been practiced. This year, at last, authorities (NCCN and FDA) recommended pre-screening but too many patients are...

A devastating loss: Dr. Anil Kapoor should still be here. DPD deficiency made standard chemotherapy deadly — and his family is bravely speaking out so no one else suffers. Dr. Vimal Scott Kapoor...

Giving Tuesday is two weeks away! AUDT is launching a critical fundraising effort with a goal of $50,000 for Giving Tuesday. These funds will allow AUDT to continue our momentum through 2026 by: ·...

Well stated Karen. Thank you for your tireless advocacy!

"Testing should be adopted immediately as the standard of care." Advocates for Universal DPD/DPYD Testing

Thankful to those who have worked hard advocating for patient safety! 2025 has been a pivotal year ----->

Patient advocates celebrating National Comprehensive Cancer Network® (NCCN®) colon cancer guidelines update- recommending pretreatment DPYD testing BEFORE capecitabine and fluorouracil. Advocates for...

📣 📣 📣 NCCN updated Colon cancer guidelines today, 10/30/2025! 🔔 🔔 🔔 FDA says test. NCCN says test . Now every cancer center must implement testing. Protect patients. Test DPYD before chemo. |...

Thank you HOPA for this announcement and your Excellent summary of the next steps needed to extend this life saving practice to all.

What we are reading: A prospective, nonrandomized implementation trial conducted in three oncology care sites included adult patients with gastrointestinal cancers and plans to begin treatment with a...

Incredible news!! As of 10/3/2025 the U.S. FDA now includes a Boxed Warning on the Xeloda (capecitabine) drug label that says: “Test patients for genetic variants of DPYD prior to initiating Xeloda...

This should get people’s attention! No equivocation here by the FDA. Test before using the drug. Expect a similar box warning to follow for 5-FU. So many people to thank for making this happen: your...

▶️ Dihydropyrimidine dehydrogenase (DPYD) genetic variants can lead to severe, sometimes fatal, reactions to common chemotherapy drugs like 5-FU and capecitabine. In one of the largest population...

FDA It is time to make pretreatment DPYD testing mandatory in the labels for 5FU and capecitabine. #patientsafety | 11 comments on LinkedIn